(Q33814828)

29 July 2017

1 reference

title

Neoplastic complications of HIV infection (English)

1 reference

ORCID Public Data File 2021

29 July 2017

1 reference

author name string

M Spina

1

1 reference

29 July 2017

E Vaccher

2

1 reference

29 July 2017

A Carbone

3

1 reference

29 July 2017

U Tirelli

4

1 reference

29 July 2017

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

issue

11

1 reference

29 July 2017

page(s)

1271-1286

1 reference

An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASES

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Malignant lymphomas in a population at risk for acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Unusual malignant tumours in 49 patients with HIV infection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Kaposi's sarcoma in recipients of renal transplants

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Kaposi's sarcoma after long-term alkylating agent therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The epidemiology of acquired immunodeficiency syndrome and associated tumours in Europe

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug users as the main group affected by HIV infection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Clinical aspects of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Evidence of activity of vinorelbine in patients with previously treated AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The epidemiology of acquired immunodeficiency syndrome-related lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with othe

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

HIV-associated human herpesvirus 8-positive primary lymphomatous effusions: radiologic findings in six patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Molecular and pathologic characterization of an AIDS-related body cavity-based lymphoma, including ultrastructural demonstration of human herpesvirus-8: a case report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Clinical Evaluation of 451 Patients with HIV Related Non-Hodgkin's Lymphoma: Experience of the Italian Cooperative Group on AIDS and Tumors (GICAT)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Spectrum of AIDS-associated malignant disorders

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Hodgkin's disease in 92 patients with HIV infection: The Italian experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Human immunodeficiency virus infection and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Human immunodeficiency virus infection and genital warts as risk factors for anal intraepithelial neoplasia in homosexual men.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

ASSOCIATION BETWEEN ANORECTAL DYSPLASIA, HUMAN PAPILLOMAVIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL MEN

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative men.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Changing patterns of anal cancer incidence in the United States, 1940-1989.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008390028330

7 January 2021

Identifiers

DOI

10.1023/A:1008390028330

1 reference

29 July 2017

1 reference